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Abstract
The role of Melanocortin 2 Receptor (MC2R) in adrenal/interrenal glucocorticoid
secretion has been well documented in many organisms. Studies in mammals have shown
that in the adrenal gland two melanocortin receptors and two melanocortin receptor
accessory proteins are expressed: MC2R, MC5R, MRAP, and MRAP2. The MRAPs
have an opposite effect on the cell surface expression of MC2R and MC5R. In mammals,
MRAP aids MC2R but inhibits MC5R cell surface expression. This thesis aims to explore
the functional relationship between MC2R, MC5R, MRAP, and MRAP2 in Xenopus
tropicalis to determine if the MRAPs have a similar effect on amphibian MC2R and
MC5R when the receptors are stimulated with ACTH, or -MSH. Expression of these
four genes in the frog interrenal was verified through RT-PCR. Then CHO-K1 cells were
transfected with plasmid constructs containing X. tropicalis MC2R, MC5R, MRAP2, and
a mouse MRAP, and stimulated with ACTH or -MSH. Levels of receptor activation
were measured using a CRE-luciferase reporter gene. The findings presented here
indicate that in the frog the MRAPs do not have a negative effect on MC5R, since
activation of MC5R was not inhibited in the presence of MRAPs. The sensitivity of
MC5R for ACTH increased from an EC50 of 1.2 x 10-9 M to an EC50 of 8.7 x 10-11 M in
the presence of MRAP (p<0.05) and to an EC50 of 1.3 x 10-10 M in the presence of
MRAP2 (p<0.01).
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Introduction
The mammalian melanocortin system is composed of five distinct melanocortin
receptors: MC1R-MC5R, two accessory proteins: MRAP and MRAP2, the melanocortin
ligands: ACTH, --and -MSH, and two endogenous antagonists: agouti and AGRP.
Melanocortin Receptors (MCRs)
Melanocortin receptors (MCRs) belong to the Class A family of G-protein
coupled receptors (GPCRs), which fall under the same family as the rhodopsin/2adrenergic-like receptors (Rodrigues et al., 2013). A common characteristic of all GPCRs
is that they consist of seven -helical transmembrane-spanning domains that are
connected by alternating intracellular and extracellular loops (Rosenbaum et al., 2006).
MCRs couple to an intracellular heterotrimeric G-protein, with a stimulatory G subunit
that when activated will stimulate the production of cyclic adenosine monophosphate
(cAMP) via adenylyl cyclase (Figure 1). This intracellular buildup of cAMP, will
generate downstream signaling through activation of protein kinase A (PKA) (Gantz and
Fong, 2003; Rosenbaum et al., 2006). MCRs are considered to be the smallest GPCRs
that have been identified since they have short domains in the extracellular N-terminal
and intracellular C-terminal, small fourth and fifth transmembrane-spanning domains,
and a very small second extracellular loop (Mountjoy et al., 1992). Currently, five
melanocortin receptors have been cloned, and they are numbered consecutively in the
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Figure 1: GPCR/adenylyl cyclase signaling transduction pathway. Signaling begins
when the ligand/hormone binds to the G-protein coupled receptor (GPCR) and this causes
a conformational change in the intracellular heterotrimeric G-protein. This results in the
activation of the G-subunit that will stimulate adenylyl cyclase to produce cAMP.
cAMP will build up in the cytoplasm and act as a second messenger to activate protein
kinase A (PKA).
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order of their discovery: MC1R, MC2R, MC3R, MC4R, and MC5R (Rodrigues et al.,
2013). These receptors are involved in a wide range of physiological functions such as
skin and hair pigmentation, inflammation, glucocorticoid secretion, energy homeostasis,
appetite regulation, sexual function, and sebaceous gland secretion (Yang, 2011).
Proopiomelanocortin (POMC): The precursor for the MCR ligands.
Proopiomelanocortin (POMC) is placed under the opioid/orphanin gene family
and it is a precursor for -endorphin, lipotropin, and the melanocortin ligands (Dores et
al., 2002). POMC is predominantly expressed in the pituitary and the hypothalamus
(Benjannet et al., 1991) as well as keratinocytes, melanocytes and some peripheral tissues
such as GI-tract, adrenal, spleen, lung, thyroid and some cells of the immune system
(Gantz and Fong, 2003). In the anterior pituitary, POMC is expressed by the corticotropic
cells and processed into ACTH and -lipotropin; whereas in the intermediate pituitary the
melanotropic cells will process POMC into --and -MSH, -endorphin, and
corticotropic-like intermediate lobe peptide (CLIP) (Dores et al., 2002). POMC is a
biologically inactive molecule until it undergoes proteolytic cleavage at specific pairs of
amino acids by enzymes known as prohormone convertases PC1/3 and PC2 (Benjannet et
al., 1991; Catania et al., 2004). As shown in Figure 2, these enzymes will process POMC
to yield the melanocortin ligands, which are the melanocyte stimulating hormones MSH, -MSH, and -MSH, and adrenocorticotropic hormone (ACTH). The processing of
POMC is tissue specific and different cell types will produce different melanocortin
ligands depending on which enzymes, PC1/3, PC2, and other processing enzymes are
present (Gantz and Fong 2003). A common feature of the melanocortin ligands is that

3

Figure 2: Processing of Proopiomelanocortin (POMC). Enzymes involved in the
posttranslational processing of POMC in the pituitary to produce the melanocortin
ligands ACTH, -MSH, -MSH, and -MSH (Figure from Patel et al., 2011).
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they all share the His-Phe-Arg-Trp (HFRW) motif (Catania et al., 2004), which is
required for proper activation of MCRs as well as the Lys-Lys-Arg-Arg-Pro (KKRRP)
motif in ACTH (Costa et al., 2004; Liang et al., 2013). MCRs have a varying degree of
affinity for the ligands that are derived from the precursor peptide hormone POMC, as
well as for two known antagonists: agouti and agouti-related peptide (AGRP) (Table 1)
(Gantz and Fong, 2003).
Activation of Mammalian MC1R, MC3R, MC4R and MC5R by the POMC derived
ligands
Out of all the melanocortin ligands, MC1R seems to have the highest affinity for
-MSH (Gantz and Fong, 2003). MC1R is mainly expressed in melanocytes (Mountjoy
et al., 1992) where it mediates skin and hair pigmentation. MC1R has also been found in
other cell types such as keratinocytes, fibroblasts, endothelial cells, and other immune
cells (Gantz and Fong, 2003). Some studies have also investigated the involvement of
MC1R in the anti-inflammatory process (Catania et al., 1996; Lipton and Catania, 1997).
MC3R has been linked to energy homeostasis due to its expression in the regions
of the central nervous system (CNS) known to control feeding behavior. It is largely
expressed in the cortex, thalamus, hippocampus, hypothalamus, GI-tract, and placenta. It
can bind ACTH and the MSH-ligands roughly with equal affinity (Gantz et al., 1993;
Gantz and Fong 2003).
Similar to MC3R, MC4R is expressed in the CNS and is also involved in energy
homeostasis, in addition to the regulation of sexual function (Gantz and Fong, 2003).
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Table 1: Function of the melanocortin receptors, ligands, and antagonists. Ligand
selectivity of the receptors for the proopiomelanocortin (POMC) derived ligands:
melanocyte stimulating hormones (--and -MSH), and adrenocorticotropic hormone
(ACTH). Agouti has the ability to bind and antagonize all the receptors, with the
exception of MC5R. Agouti-related peptide (AGRP) can potentially regulate the activity
of MC3R and MC4R. There is no known antagonist for MC5R.
Receptor

Ligand selectivity

Antagonists

Function

MC1R

-MSH=ACTH > -MSH > -MSH

Agouti

Pigmentation,
inflammation

MC2R

ACTH

Agouti

Steroidogenesis

MC3R

-MSH=-MSH = -MSH=ACTH

Agouti, AGRP

Energy homeostasis

MC4R

-MSH=ACTH > -MSH > -MSH

Agouti, AGRP

Energy homeostasis,
erectile function

MC5R

-MSH > ACTH > -MSH > -MSH

*Adapted from Gantz and Fong, 2003.
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Sebaceous gland
secretion

Deleting this receptor in mice, results in an obese phenotype consistent with hyperphagia,
hyperinsulinemia, and hyperglycemia, which suggests that MC4R plays a role in
regulating feeding behavior (Huszar et al, 1997).
The last melanocortin receptor to be cloned was MC5R. This receptor has a wide
range of tissue distribution with detectable expression levels in skeletal muscle, brain,
RT2-2 retinal neuronal cells, lung, spleen, kidney, testis, heart, liver (Fathi et al., 1995)
and adrenal gland (Sebag and Hinkle, 2009a). Also, it has been detected in numerous
exocrine tissues like Harderian gland, lacrimal, preputial, and sebaceous glands (Chen et
al., 1997). There is not much is currently known about the function of this receptor in all
of these tissues. However, its role in exocrine gland secretion was determined by targeted
deletion of MC5R in mice, and the observation that mutant mice exhibited defects in
thermoregulation due to decreased surface lipids, along with decreased secretion of
proteins from the lacrimal gland, and a deficiency of porphyrin from the Harderian glands
compared to wild type littermates (Chen et al., 1997). In mammals, this receptor seems to
have a preference for -MSH (Gantz and Fong 2003).
Melanocortin 2 Receptor (MC2R): The ACTH-Receptor
MC2R was the second melanocortin receptor to be characterized (Mountjoy et al.,
1992). MC2R is expressed in murine adipocytes (Catania et al., 2004), but it is primarily
involved in stress regulation via the Hypothalamic-Pituitary-Adrenal (HPA) Axis. MC2R
is also known as the ACTH-receptor because it exclusively binds ACTH, and unlike the
other MCRs, it does not bind any of the MSH-ligands (Gantz and Fong, 2003). MC2R is
expressed in the adrenal cortex zona fasciculata and part of the zona glomerulosa, which
are sites involved in the synthesis and release of glucocorticoids (Mountjoy et al., 1992;
7

Xia and Wikberg, 1996). The finding that roughly 25% of individuals with a rare disease,
known as Familial Glucocorticoid Deficiency (FGD) Type 1, have mutations in MC2R
supports the involvement of this receptor in regulating glucocorticoid secretion (Chung et
al., 2008). Some of the phenotypes associated with individuals suffering from FGD are
low levels of cortisol (a glucocorticoid), insensitivity to ACTH, hypoglycemia,
susceptibility to infections, and intense skin pigmentation. This disease can be fatal in
early childhood if left untreated (Metherell et al., 2005; Chung et al., 2008).
Another unique aspect of MC2R is that since its discovery in 1992, many
researchers failed to functionally express MC2R in heterologous mammalian cell lines
unless the receptor was expressed in an adrenal-derived cell line. Noon et al. (2002) were
the first to suggest that MC2R must require an adrenal-specific accessory factor, such as
a chaperone, that enabled proper trafficking to the plasma membrane and activation by
ACTH. This observation was based on the fact that the same epitope-tagged version of
the receptor would function properly if expressed in an adrenal cell line, but not in other
cell types. Thus, MC2R must be interacting with another “cofactor” that is specifically
expressed in adrenal cells. A few years later that interacting partner was identified and
named Melanocortin 2 Receptor Accessory Protein (MRAP).
Melanocortin 2 Receptor Accessory Protein (MRAP)
The eventual discovery of MRAP was done by comparing individuals with FGD
Type 2 and their unaffected family members through microarray analysis of SNPs, and
this revealed a region on a chromosome that codes for a small protein that is now known
as Melanocortin 2 Receptor Accessory Protein (MRAP) (Metherell et al., 2005).
Individuals are diagnosed with FGD Type 2 because they lack mutations in MC2R, but
8

regardless of having an intact receptor they still display phenotypes associated with FGD,
such as resistance to ACTH and a deficiency in cortisol production. Metherell et al.
(2005) also proved that this small protein consists of a single transmembrane-spanning
domain. When MRAP is coexpressed with MC2R in a non-adrenal cell line, it allows for
the proper trafficking of MC2R to the plasma membrane as well as activation by ACTH.
Further studies on the structure of this protein have shown that MRAP forms homodimers
(Cooray et al., 2008) and that these two proteins are oriented in an anti-parallel manner
with one MRAP being oriented with its N-terminal facing the exterior environment and
the other MRAP with its N-terminal facing the cytoplasm. These dual orientations of
MRAP homodimers form a stable interaction with MC2R (Sebag and Hinkle, 2007).
A homologue of MRAP was later discovered, called MRAP2, which is 39%
identical to MRAP in amino acid sequence at the N-terminal and transmembrane domain
(Chan et al., 2009). MRAP2 can interact with MC2R in vitro and enables receptor
trafficking to the cell surface, but it is not nearly as efficient as MRAP when the cells are
stimulated with ACTH (Chan et al., 2009; Sebag and Hinkle 2010). MRAP2 is similar to
MRAP in that it also consists of a single transmembrane-spanning domain, forms
homodimers, and can form a heterodimer with MRAP (Chan et al., 2009); but differs in
that it lacks an important LDYI motif, which is necessary for MC2R activation by ACTH
(Sebag and Hinkle, 2009b). These two accessory proteins interact with all five MCRs and
have the potential to regulate their function by increasing/decreasing cell surface
expression, in addition to the ligand affinity of the receptor (Chan et al., 2009; CerdáReverter et al., 2013).
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Studies on the evolutionary origin of MCRs propose that MCRs are the result of
two genome duplication events and one local gene duplication that occurred during the
evolution of the chordates. The evolution of MCRs is also closely linked to the coevolution of POMC, MRAPs, and the AGRP/ASIP gene families (Dores, 2013). The
discovery of an MRAP-independent MC2R in the cartilaginous fish Callorhinchus milii,
which can be functionally activated by either ACTH or any of the MSH-ligands (Reinick
et al., 2012), suggests that the ancestral MC2R must have been MRAP-independent. As
mutations accumulated in both MC2R and MRAP, the receptor and the accessory protein
developed a functional relationship where MRAP is required to facilitate MC2R
trafficking to the plasma membrane and activation by ACTH (Dores, 2013). This
interaction of MC2R with MRAP, and the ligand selectivity for ACTH has been well
established not only for mammals, but also for birds (Barlock et al., 2014), fish
(Agulleiro et al., 2010), and amphibians (Liang et al., 2011).
The Hypothalamic-Pituitary-Adrenal (HPA) Axis
In mammals, the Hypothalamic-Pituitary-Adrenal (HPA) Axis is a regulated
system of signaling events that lead to the synthesis and release of glucocorticoids from
the adrenal cortex in a circadian pattern and in response to organismal stress. Signaling
begins after the parvocellular neurons in the hypothalamus release corticotropin-releasing
hormone (CRH) directly into the median eminence of the anterior pituitary via the
Pituitary Portal Vein. CRH will bind to receptors on corticotropic cells where ACTH will
be synthesized and released into the vascular system. Then ACTH will bind to and
activate MC2R in the glucocorticoid producing cells in the adrenal cortex leading to the
synthesis and release of cortisol (Figure 3). Glucocorticoids will induce several
10

Figure 3: The Hypothalamic-Pituitary-Adrenal (HPA) Axis. The cerebral cortex will
signal the hypothalamus to release corticotropin-releasing hormone (CRH) directly to the
anterior pituitary, where the precursor hormone proopiomelanocortin (POMC) will be
processed into ACTH and released into the bloodstream. ACTH will reach the adrenal
gland and will induce the synthesis and release of cortisol. Cortisol will reach its target
tissues and will also negatively feedback (-) to stop the release of CRH in the
hypothalamus and to stop the synthesis and release of ACTH in the pituitary.
*Illustration adapted with artist permission (Samson, 2012).
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physiological changes in the organism such as improvement in motor reflexes, cognitive
function, alertness, pain tolerance, and decreased appetite and sexual arousal.
Glucocorticoids will also regulate the HPA-axis, through a negative feedback loop, in
order to stop the release of CRH in the hypothalamus and to stop the synthesis and
release of ACTH in the pituitary (For review see Papadimitriou and Priftis, 2009).
The HPA-axis is an evolutionary conserved response to stress and a similar
system exists in fish and amphibians. The interrenal tissue in the head kidney of fish and
the interrenal tissue in amphibians is the equivalent to the adrenals in mammals;
therefore, in these species the HPA-axis is referred to as the Hypothalamic-PituitaryInterrenal (HPI) Axis. The interrenal tissue contains the glucocorticoid producing cells
and stress activation is also in response to ACTH via an MRAP-dependent MC2R.
A closer look at the Adrenal/Interrenal
MC2R and MC5R are coexpressed in the mammalian adrenal gland (Sebag and
Hinkle, 2009a) and in the interrenal tissue of fish (Kobayashi et al., 2011), which is
relevant to this study because despite the presence of MC5R, -MSH does not induce
glucocorticoid secretion in vivo (Kobayashi et al., 2011; Aluru and Vijayan 2008). In the
mammalian adrenal gland, the two accessory proteins MRAP and MRAP2 are also
expressed (Sebag and Hinkle, 2009a) and studies dating back to the 1970’s have shown
that α-MSH does not stimulate the mammalian adrenal cortex to release glucocorticoids
(Schwyzer, 1977).
In trying to characterize the functional interaction of these proteins, Sebag and
Hinkle (2009a) found that MC2R requires MRAP for trafficking to the plasma
membrane, but when MC5R was coexpressed with either of the accessory proteins,
12

MRAP or MRAP2, the receptor failed to reach the cell surface and was trapped in the
endoplasmic reticulum (ER) (See Figure 4). Based on their observations it seems that in
the mammalian system MC2R will preferentially bind MRAP to reach the cell surface
and to be activated by ACTH, and the interaction of MC5R with either MRAP or
MRAP2 will have a negative effect on the receptor by interfering with the ability of the
receptor to dimerize (Figure 4). These observations raise some interesting questions about
how the stress response has evolved and how these proteins might interact in other
systems such as in fish and amphibians.
Objectives and Hypotheses
This study will use Xenopus tropicalis as a model system to test the hypothesis
that the interaction of MC2R, MC5R, MRAP, and MRAP2 in the interrenal tissue of
amphibians is similar to that previously reported for the mammalian adrenal gland. It is
hypothesized that all of these proteins will be found in the interrenal tissue of the frog.
Therefore, it is expected that MRAP will aid MC2R translocation to the plasma
membrane and activation by ACTH, but MRAP or MRAP2 will prevent MC5R from
reaching the cell surface and this will inhibit activation by either ACTH or -MSH. It is
also hypothesized that MRAP does exist in the Xenopus tropicalis genome. In the
genome of Xenopus tropicalis all five receptors and MRAP2 have been sequenced, but
the sequence for MRAP has not yet been identified. This will be accomplished through
RNA extraction, cDNA synthesis, and PCR on the interrenal tissue of Xenopus tropicalis
using gene specific primers for MC2R, MC5R, and MRAP2, and degenerate primers
from conserved regions of MRAP.
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This study will also make use of an in vitro approach doing transient transfections
with CHO cells and using different combinations of cDNA constructs of Xenopus
tropicalis MC2R, MC5R, MRAP2 and Mus musculus MRAP to test the interaction of
these proteins. To measure cAMP production upon stimulation with ACTH or -MSH,
the CHO cells will also be transfected with a CRE-Luciferase reporter gene.
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Figure 4: Observations from Sebag and Hinkle (2009) on the opposite effect that
MRAP/MRAP2 have on MC2R and MC5R. A. MRAP and MRAP2 will promote
trafficking of MC2R to the plasma membrane. However, MRAP is much more effective
and required for activation of MC2R by ACTH. B. MRAP and MRAP2 will prevent
dimerization of MC5R and will prevent the receptor from reaching the cell surface. C. In
the adrenal cell all four: MC2R, MC5R, MRAP, and MRAP2 are expressed, but it is still
not well understood how these four proteins interact.
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Materials and Methods
Total RNA extraction
Mature female Xenopus tropicalis, six months or older, were purchased from
Nasco (Modesto, CA) for tissue dissection. The frogs were first anesthetized with MS222 (Sigma-Aldrich) followed by decapitation. Tissues were extracted and frozen
immediately on dry ice and stored at -80C for subsequent use in RNA extraction. Tissue
dissections were done by Dr. Robert Dores and approved by the University of Denver
Institutional Animal Care and Use Committee (IACUC Approval #472436-1).
A section of interrenal/kidney tissue (between 50-100mg) was used for total RNA
extraction using 1mL of TRIzol Reagent in a glass-Teflon homogenizer. After the
tissue was homogenized on ice, it was transferred into a 1.75mL microcentrifuge tube
and was centrifuged at 12,000 x g for 10 minutes at 4C. The supernatant was transferred
to a clean microcentrifuge tube and incubated at room temperature for 5 minutes. 200L
of phenol-chloroform-isoamyl alcohol was added and the tube was shaken vigorously by
hand. After 3 minutes at room temperature, the sample was centrifuged again at 12,000 x
g for 15 minutes at 4C and the upper aqueous phase, which contains the RNA, was
transferred into to a clean microcentrifuge tube. The RNA was precipitated by using
500L isopropyl alcohol and incubated at room temperature for 10 minutes, followed by
centrifugation at 12,000 x g for 10 minutes at 4C. The supernatant was removed and the
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RNA pellet was washed with 1mL RNase-free 75% EtOH, vortexed briefly, and then
centrifuged at 7,500 x g for 5 minutes at 4C. The RNA pellet was air dried for 10
minutes, and dissolved in 30L RNase-free water. Afterwards, DNA-free DNase
Treatment & Removal (Ambion, Life Technologies) was used to remove any genomic
DNA contamination in the sample. The total RNA was treated with 1L 10x DNase I
Buffer and 1L rDNase I and incubated at 37C for 30 minutes. Then 2L of DNase
Inactivation was added, incubated at room temperature for 2 minutes and centrifuged at
10,000 x g for 1.5 minutes. The supernatant was transferred to a clean microfuge tube,
leaving the pellet with any genomic DNA contamination behind. RNA concentration was
measured using NanoDrop 2000 Spectrophotometer (Thermo Scientific), and the tube
was stored at -80C.
The same protocol was repeated using 50-100mg of Xenopus tropicalis heart,
brain, liver, muscle, ovaries, and intestinal tissue for expression patterns of MC2R,
MC5R, MRAP, and MRAP2 through cDNA synthesis and PCR.
cDNA Synthesis
cDNA synthesis was performed using SuperScript III First Strand Synthesis
System for RT-PCR (Invitrogen) following manufacturer’s instructions. The reaction was
carried out using Oligo(dT)20 primer and 0.5g of total RNA was used per reaction. For
the negative control, reverse transcriptase was omitted from the reaction components.
PCR
Gene specific primers were designed for X. tropicalis MC2R, MC5R, and
MRAP2 from sequences obtained from www.xenbase.org and www.ncbi.nlm.nih.gov.
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Degenerate primers were designed for MRAP based on regions of sequence conservation
for the MRAP sequences of human, mouse, chicken, rat, rhesus macaque, rainbow trout,
and Chinese soft-shelled turtle. The primers were ordered from Integrated DNA
Technologies (www.idtdna.org). Primer sequences, annealing temperature (Ta), and
expected size PCR products are listed in Table 2. A standard 20L PCR reaction was set
up using 2L 10X PCR buffer, 0.6L 50mM MgCl2, 2L 10mM dNTPs, 2L 10M
Forward Primer, 2L 10M Reverse Primer, 0.2L Taq Polymerase 5U/L (Invitrogen),
9.2L sterile water, and 2-3L interrenal/kidney cDNA or negative control. A positive
control was also set up with plasmid cDNA constructs containing the full-length
xtMC2R, xtMC5R, and xtMRAP2. Five 20l PCR reactions were done for each gene.
The cycling parameters for the thermal cycler were: initial denaturation at 94C for 3
minutes, a second denaturation at 94C for 45 seconds, primer annealing for 30 seconds,
primer extension at 72C for 1 minute and 30 seconds, cycle 32 times to second
denaturation step, a final extension at 72C for 10 minutes, and reaction was held at 4C.
The PCR reactions for each respective gene were combined and purified using QIAquick
PCR purification kit (Qiagen). 5L 6X loading dye was added to each PCR reaction and
the PCR products were ran at 60 Volts for 1 hour on a 2% TAE gel stained with Ethidium
Bromide for visualization using Quantity One Gel Doc Imager (BioRad). exACTGene
Low Range Plus DNA Ladder (Fisher Scientific) was used to verify the size of products.
The bands were excised from the gel based on the expected product length and purified
using Wizard SV Gel and PCR Clean-Up System (Promega) and stored at -20C. If PCR
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Table 2: Sequences of X. tropicalis gene specific PCR primers for MC2R, MC5R,
MRAP2, and degenerate PCR primers for MRAP. Annealing temperature (Ta) for each
primer pair and expected size of PCR product in base pairs (bp).

Gene

Primer Sequence

Ta

Size

xtMC2R

Forward:
5’ GGTGCTCCTAGCTGTGATAAA 3’
Reverse:
5’ GGAGACCAACAGCAAATGAATA 3’

59.8C 594 bp

xtMC5R

Forward:
5’ AATACAGTGCCAACTGGAAAG 3’
Reverse:
5’ CTTCATGCTTGTTCTCTGGTG 3’

61.6C 645 bp

xtMRAP

Degenerate Forward:
5’ ATGGCCAACRGRACMRACKCMTCTG 3’
61.6C 185 bp
Degenerate Reverse:
5’ CRGGACATGTAGAGCARRATRARRAA 3’

Forward:
5’ AAGCAGTTGTCCAATTCTGATTAC 3’
xtMRAP2
Reverse:
5’ GAGAGACCGTGATTCTTCTGTT 3’
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57C

312 bp

yielded a faint band, the excised band that was purified was submitted through another
round of PCR to increase product yield.
Ligation and Bacterial Transformation
The purified gel products: MC2R, MC5R, MRAP, and MRAP2 were ligated into
pGEM-T Easy Vector System I (Promega) using 3L of PCR product and left overnight
at 4C. Mix & Go Competent DH5 E. coli cells (Zymo Research) were used for
transforming 3-5L of each of the ligations according to manufacturer’s instructions. The
cells were plated on LB-Agar+Carbenicillin/X-gal/IPTG and incubated overnight at
37C. Colonies were selected based on blue/white screening and insert was verified using
PCR with SP6 and T7 primers. White colonies were picked with a sterile toothpick and
resuspended in microfuge tubes with 20L sterile water. They were heated for 2 minutes
at 96C and 2L was added to a tube containing PCR mix (as previously described, but
with an extra 5L sterile water). The same PCR cycling parameters mentioned above
were used, but with a primer annealing temperature of 55C. A 20L aliquot was taken
from each PCR reaction and stored at 4C and the remaining 5L were run on a 2% TAE
gel to verify the correct size of insert in the plasmid. The 20L PCR reactions for the
colonies that were positive for the insert were treated with 0.5L Exonuclease I (USB)
and 0.5L Shrimp Alkaline Phosphatase (USB) and incubated at 37C for 45 minutes and
at 80C for 45 minutes to degrade any remaining primers and dNTPs. These PCR
samples were sent for sequencing with SP6 or T7 primer at the University of Colorado
DNA Sequencing & Analysis Service.

20

Cell Line
Adherent Chinese Hamster Ovary cells (CHO-K1) from ATCC, were grown in a
25cm2 cell culture flask with a vented cap with CHO Media prepared by using Kaighn’s
Modification of Ham’s F-12 Medium (F-12K) supplemented with 10% Fetal Bovine
Serum, 1% penicillin/streptomycin, and 1 mg/ml Normocin(InvivoGen). The cells were
maintained in a 37C incubator with a relative humidity of 80-90%, and 5% CO2. CHO
cells were sub-cultured when they reached about 90% confluence. The media was
removed and the cells were rinsed with 3 mL 1X phosphate buffered saline (PBS). 2mL
of Trypisn/0.53mM EDTA was added and incubated at 37C for 3 minutes to aid cell
detachment. Then 3 mL fresh CHO media was added to inactivate the trypsin. The cells
were either counted with a hemocytometer for use in transfection experiments, or a small
aliquot was subcultured in a new flask with fresh media being renewed between
subcultures.
Plasmid Constructs
cDNA plasmid constructs were synthesized by GenScript (Piscataway, NJ) in a
pcDNA3.1(+) vector: Xenopus tropicalis MC2R with a FLAG epitope tag at the Nterminal, Xenopus tropicalis MC5R, Xenopus tropicalis MRAP2 with a FLAG epitope
tag at the N-terminal, Mus musculus MRAP, Xenopus tropicalis MC5R mutant with
alanine substitutions at positions 92, 114, and 119, Xenopus tropicalis MC2R mutant
with an alanine substitution at isoleucine 175 (xtMC2R I-175), and a Gallus gallus
MRAP with a FLAG epitope tag at the N-terminal.
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cAMP Assay using a CRE-Luciferase Reporter Gene
CHO cells were transiently transfected using the Amaxa Nucleofector II Device
and the Cell Line Nucleofector Kit T (Lonza). For each transfection 2.5x106 cells were
used with 100L of Solution T and 2g of different combinations of cDNA plasmid
constructs. All transfections contained 2g of the CRE-Luciferase Reporter cDNA
plasmid construct, kindly donated by Dr. Patricia M. Hinkle. The cells were transfected
using Program U-023. After transfection, the cells were allowed to recover for 10
minutes in 500L of CHO media in the 37C incubator. Then the cells were diluted in
7.5mL of CHO media and plated in a 96-well plate at a density of approximately 1x105
cells per well. Each transfection was plated, three columns per transfection, so each plate
could hold a total of four transfections. The plate was placed in the 37C incubator with
fresh media being replaced 24 hours after transfection. 48 hours post-transfection the
cells were stimulated with varying peptide concentrations of frog ACTH 1-24 or frog MSH prepared in Serum-Free CHO Medium (F-12K Medium, 1 mg/ml BSA, and 1%
penicillin/streptomycin). The stimulating solutions ranged in concentration from the
control, which was Serum-Free CHO Medium only, and 10-12 M to 10-6 M. Each
concentration was done in triplicates. After a period of four hours in the 37C incubator,
the plate was allowed to sit at room temperature for 10 minutes. The stimulating solutions
were removed and 100L of a 1:1 ratio of Serum-Free CHO Medium and luciferase
substrate (Bright-Glo Luciferase Assay System, Promega) was added to each well. After
five minutes at room temperature, luminescence was read using the Bio-Tek Synergy HT
Plate Reader. For each transfection the average control value was subtracted from each
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experimental value, and the mean for each data point was graphed using KaleidaGraph
Software. A Micahelis-Menten curve was fit through the data points to obtain an EC50
value as well as standard error. Comparison of the EC50 values were done using a
Student’s t-test with equal variance and significance set at p<0.05.
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Results
Cloning MC2R, MC5R, MRAP, and MRAP2
PCR on interrenal/kidney tissue
PCR was performed using cDNA synthesized from X. tropicalis interrenal/kidney
tissue in order to verify the presence of MC2R, MC5R, MRAP, and MRAP2 (Figure 5).
The interrenal tissue was difficult to extract without taking a small portion of the kidney,
so it is labeled as interrenal/kidney tissue. A band consistent with the expected product
size was observed for each gene: MC2R (594bp), MC5R (645bp), MRAP (185bp), and
MRAP2 (312bp). No visible band was detected in any of the negative controls (Lane 1:
5A, 5B, 5C, 5D), which had all the RT-PCR components with the exception of reverse
transcriptase. The band for each gene that was amplified from the cDNA was excised
from the gel, ligated into a vector, and sequenced to confirm that the primers had
amplified the gene of interest. Figure 6 shows the full-length nucleotide and amino acid
sequence of MC2R with the primer regions in bold and the underlined 594 base pair
region that was verified through sequencing. The same was done for MC5R (Figure 7)
and underlined is the 645 base pair region that was sequenced, as well as the 312 base
pair region that was sequenced for MRAP2 (Figure 8). For MRAP, a 185 base pair region
was amplified with the degenerate primers and when sequenced matched the chicken
MRAP. An alignment of the nucleotide and amino acid sequence was done to show
sequence homology between the chicken MRAP and the sequence that was obtained from
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Figure 5: Gel electrophoresis of PCR fragments of MC2R, MC5R, MRAP, and MRAP2
(A-D) using cDNA synthesized from X. tropicalis interrenal/kidney tissue. Ladder (L)
sizes in base pairs (bp) listed on the right panel. A. MC2R (594 bp): Lane 1-Negative
control (no reverse transcriptase (RT)), Lane 2-Positive control-plasmid containing fulllength xtMC2R insert, Lane 3- cDNA. B. MC5R (645 bp): Lane 1-Negative control (no
RT), Lane 2-Positive control-plasmid containing full-length xtMC5R insert, Lane 3cDNA. C. MRAP (185 bp): Lane 1-Negative control (no RT), Lane 2- cDNA. D.
MRAP2 (312 bp): Lane 1-Negative control (no RT), Lane 2-Positive control-plasmid
containing full-length xtMRAP2 insert, Lane 3- cDNA.
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MC2R
atggatatagcaaatgaaatcggaaggcaacacactggtatgaagaatgtgacaatcctg
M D I A N E I G R Q H T G M K N V T I L
tcagtgaacagcacaaaatgttccagcgttcatgttccagaggtggtgtacctaaccgta
S V N S T K C S S V H V P E V V Y L T V
FORWARD PRIMER 
tctgctattggtctcctggaaaatctgctggtgctcctagctgtgataaaaaataaaaat
S A I G L L E N L L V L L A V I K N K N

20
40

60

cttcacttgcccatgtactttttcatttgtagtttggcagtctccgatatgctgttcagt
L H L P M Y F F I C S L A V S D M L F S

80

ctatacaaaattctcgagaccattataataattttagccaacattggtttcctggataga
L Y K I L E T I I I I L A N I G F L D R

100

aatgggcctttcgaaaaaaagatggatgatgtaatggactggatctttgttctttcatta
N G P F E K K M D D V M D W I F V L S L

120

cttggatcaatctttagcatatctgcgattgcagctgacagatacattactgtttttcat
L G S I F S I S A I A A D R Y I T V F H

140

gcactgcattaccataatatcatgactgtaaaaagagcttcagtcatattagcagtaatt
A L H Y H N I M T V K R A S V I L A V I

160

tggacattttgtggtggaagtggaatagctataattatgctgtttcatgatacggcaatg
W T F C G G S G I A I I M L F H D T A M

180

ataatatgtctcactgttatgttcctattattattagttttgatagtttgcctttacatc
I I C L T V M F L L L L V L I V C L Y I

200

catatgtttcttctagctcgatcacatgccaaaaaaattgcatctctatccggacaatgg
H M F L L A R S H A K K I A S L S G Q W

220

aattctgttcagcaacgggctaacataaatggagcgattactttgaccattttacttgga
N S V Q Q R A N I N G A I T L T I L L G
REVERSE PRIMER
ctattcatttgctgttggtctccatttgttctgcatcttctgttatatgtattatgccga
L F I C C W S P F V L H L L L Y V L C R

260

tataatccatattgtgcctgttatttgtccatgttaaatgtgaacggtacacttatattg
Y N P Y C A C Y L S M L N V N G T L I L

280

tttagttctgttattgaccctttaatttatgcttttcgcagccccgagctacgcaatacc
F S S V I D P L I Y A F R S P E L R N T

300

ttcaaaaaaatgttatgctgttggatgacaatgtag
F K K M L C C W M T M -

311

240

Figure 6: X. tropicalis MC2R nucleotide and amino acid sequence. Underlined sequence
shows the 594 base pair region sequenced from the interrenal/kidney tissue. Sequences in
bold indicate the forward and reverse primer target sequences.
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MC5R
atgaatttatctctgcagcaatctactctagaacttaatataagtagcttgctaggaaat
M N L S L Q Q S T L E L N I S S L L G N
FORWARD PRIMER 
aatacagtgccaactggaaagactaagtcctcagcatgtgagcaagtggtaatagctgca
N T V P T G K T K S S A C E Q V V I A A

20

40

gaagttttcctcacacttggcattgtgagtctcctagaaaacattctagtcatctttgca
E V F L T L G I V S L L E N I L V I F A

60

attataaagaacaagaatttgcattcacctatgtacttttttgtatgtagcttagcagtc
I I K N K N L H S P M Y F F V C S L A V

80

gccgacatgttagttagtgtttccaatgcttgggaaaccattacaataaatctgatcaac
A D M L V S V S N A W E T I T I N L I N

100

aacaggcatctaattatggaagagacttttgtacgtcatattgacaatgtttttgattcg
N R H L I M E E T F V R H I D N V F D S

120

atgatttgtatatctgtggtggcttccatgtgcagcttgctggctatagcagtcgataga
M I C I S V V A S M C S L L A I A V D R

140

tatgtcaccatattttatgctctacgttaccataacattatgactatgagaagagctgga
Y V T I F Y A L R Y H N I M T M R R A G

160

atcatcatagcatgcatatggaccttttgcacaggatgtgggatcatcttcatactttat
I I I A C I W T F C T G C G I I F I L Y

180

tatgaatcaacatatgttataatatgtcttattacaatgtttttcactatgctttttctc
Y E S T Y V I I C L I T M F F T M L F L

200

atggtgtccttatatatacacatgttcttgttggctcgtactcatgttaagagaatagca
M V S L Y I H M F L L A R T H V K R I A
REVERSE PRIMER
gccttacctggttacaattcagttcaccagagaacaagcatgaagggagccattacctta
A L P G Y N S V H Q R T S M K G A I T L

220

240

accatactgcttggcatttttattgtctgctgggcccctttttttctccaccttattttg
T I L L G I F I V C W A P F F L H L I L

260

atgatttcctgtcctcaaaatctttattgtgtgtgttttatgtcccatttcaatatgtac
M I S C P Q N L Y C V C F M S H F N M Y

280

ctgatactaataatgtgcaattctgtaattgatcctatgatttatgcgtttcgtagtcaa
L I L I M C N S V I D P M I Y A F R S Q

300

gaaatgcgaaaaacttttaaagaaattatttgctgctatagcctgcgaatgttttgtgac
E M R K T F K E I I C C Y S L R M F C D

320

ttgcctagcaaatattaa
L P S K Y -

325

Figure 7: X. tropicalis MC5R nucleotide and amino acid sequence. Underlined sequence
shows the 645 base pair region sequenced from the interrenal/kidney tissue. Sequences in
bold indicate the forward and reverse primer target sequences.
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MRAP2
FORWARD PRIMER 
atgtctgaacaaactgttcaaacaaacagaacatcacataagcagttgtccaattctgat
M S E Q T V Q T N R T S H K Q L S N S D

20

tacacatgggaatatgaatactacgaatatgcgcctgtttcatttgaaggattaaaagct
Y T W E Y E Y Y E Y A P V S F E G L K A

40

cataaatactcaattgtaattggattctgggttggtcttgcagtctttgtcatattcatg
H K Y S I V I G F W V G L A V F V I F M

60

ttctttgttttgactttgttggccaagacaggagctcctcatcaagaaaatgttgattca
F F V L T L L A K T G A P H Q E N V D S

80

ttggagaaacaattcagaatggacagttttgcgcctgattttggaaggaacactgaagct
L E K Q F R M D S F A P D F G R N T E A
REVERSE PRIMER
gacactgacagaattttctctcgcaatgtaacagaagaatcacggtctctctttcactgc
D T D R I F S R N V T E E S R S L F H C

100

120

tacattaatgaagtggaccagccagaaagaataaagaacaggaacagagccatggacaat
Y I N E V D Q P E R I K N R N R A M D N

140

gaaattatcattcagcaaaccattagaaattccaaggtagaagaggacattaatatgatt
E I I I Q Q T I R N S K V E E D I N M I

160

gcaaagttcaacatccctaactttgttaacacagaccagagttcttcaattggtgatgat
A K F N I P N F V N T D Q S S S I G D D

180

gaccttctattatatgatccaccaatgaatttggaaaacaaagcagtccatactagtttg
D L L L Y D P P M N L E N K A V H T S L

200

tgtgactttatgaactga
C D F M N -

205

Figure 8: X. tropicalis MRAP2 nucleotide and amino acid sequence. Underlined
sequence shows the 312 base pair region sequenced from the interrenal/kidney tissue.
Sequences in bold indicate the forward and reverse primer target sequences.
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the MRAP degenerate PCR primers (Figure 9). The regions targeted by the primers are in
bold and sequence identity is highlighted in gray. The region that was sequenced from the
frog interrenal/kidney tissue contains the region of MRAP that is responsible for
trafficking to the plasma membrane and the transmembrane spanning domain (Liang et
al., 2011).
Expression of MC2R, MC5R, MRAP, MRAP2 in other tissues
The same PCR conditions that were used for the interrenal/kidney tissue were
used to look at the expression patterns of MC2R, MC5R, MRAP, and MRAP2 in the frog
heart, brain, liver, muscle, ovaries, and intestine. The interrenal/kidney was used as a
positive control in order to verify PCR efficiency and to compare the size of the expected
products in the other tissues that were analyzed. For MC2R the interrenal/kidney
(positive control) yielded the expected band of 594 base pairs (Figure 10: Lane 2). Faint
bands were also detected in the heart (Figure 10: Lane 4) and ovaries (Figure 10: Lane
12). In addition, an extremely faint band that was visible in muscle (Figure 10: Lane 10).
No visible bands were detected in any of the negative controls (Figure 10: Lanes 1, 3, 5,
7, 9, 11, 13). MC5R in interrenal/kidney (positive control) yielded the expected band of
645 base pairs (Figure 11: Lane 2) as well as a band of a similar size in the brain, muscle,
ovaries, and intestine (Figure 11: Lanes 6, 10, 12, 14 respectively). No visible bands were
detected in any of the negative controls (Figure 10: Lanes 1, 3, 5, 7, 9, 11, 13). For
MRAP, the degenerate primers yielded the expected band at about 185 base pairs for
interrenal/kidney (Figure 12: Lane 1), but no band of a similar size was detected in any of
the other tissues, or the negative controls. The expected product size of MRAP2 was 312
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MRAP NUCLEOTIDE ALIGNMENT
DEG FORWARD PRIMER 
GgMRAP ATGGCCAACA GAACAAACTC ATCTGAGTAC TTCTGGTCTT ATGAATATTA TTGGGATTAC
xt cDNA ATGGCCAACG GAACAGACGC CTCTGAGTAC TTCTGGTCTT ATGAATATTA TTGGGATTAC

60

GgMRAP ATAGATCCAA TTCCGGTAGA TGGAAGGAAG TTGAAAGTTA ATAAATATTC TATTGTCATA 120
xt cDNA ATAGATCCAA TTCCGGTAGA TGGAAGGAAG TTGAAAGTTA ATAAATATTC TATTGTCATA

GgMRAP GCCTTTTGGG TTGGACTTGC TGCCTTTGTG ATGTTTCTTT TCCTTATTTT GCTCTACATG 180
xt cDNA GCCTTTTGGG TTGGACTTGC TGCCTTTGTG ATGTTTCTTT TC-TCATCCT GCTCTACATG
DEG REVERSE PRIMER
GgMRAP TCCCGCTCTG GATCAAATCC AGTAAAACAG GTGGTCGTAA GGAACCGGGT AGAAGAAAGC 240
xt cDNA TCCCG..... .......... .......... .......... .......... ..........

GgMRAP AGTTCTAACA GTGAGCAGCC TCACGGTGAC AATCTCAGCA GTCCATTCCC AGATCCGGTT

300

GgMRAP GCTCCCGGAA CACCCAGCTG CCTTCCAGAT CACAGTGGCA TTCATGGAAG TATTTCAGCC

360

GgMRAP TGA

363

MRAP AMINO ACID ALIGNMENT
(---Traffic to PM----)

(-----Transmembrane Domain--

GgMRAP MANRTNSSEY FWSYEYYWDY IDPIPVDGRK LKVNKYSIVI AFWVGLAAFV MFLFLILLYM
xt cDNA MANGTDASEY FWSYEYYWDY IDPIPVDGRK LKVNKYSIVI AFWVGLAAFV MFLFXILLYM

60

-)

GgMRAP SRSGSNPVKQ VVVRNRVEES SSNSEQPHGD NLSSPFPDPV APGTPSCLPD HSGIHGSISA 120
xt cDNA SX........ .......... .......... .......... .......... ..........

GgMRAP

*

Figure 9: MRAP nucleotide and amino acid sequence alignments of chicken (Gg) MRAP
and X.tropicalis cDNA sequence. xt cDNA sequence was obtained from sequencing PCR
products using degenerate primers for MRAP on cDNA synthesized from frog
interrenal/kidney tissue. Sequences in bold show the degenerate forward primer and the
degenerate reverse primer target sequences and identical regions are shaded gray. The
expected product size was 185 base pairs. The amino acid alignment shows the region
responsible for trafficking to the plasma membrane (PM) and the transmembrane
spanning domain (TM).
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Figure 10: PCR analysis of tissue distribution of X. tropicalis MC2R using cDNA
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine.
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 594 base
pairs. Lane 1-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane
2-interrenal/kidney cDNA (positive control), Lane 3-Negative control of heart (no RT),
Lane 4-heart cDNA, Lane 5-Negative control of brain (no RT), Lane 6-brain cDNA,
Lane 7-Negative control of liver (no RT), Lane 8-liver cDNA, Lane 9-Negative control
of muscle (no RT), Lane 10-muscle cDNA, Lane 11-Negative control of ovaries (no RT),
Lane 12-ovaries cDNA, Lane 13-Negative control of intestine (no RT), Lane 14-intestine
cDNA.
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Figure 11: PCR analysis of tissue distribution of X. tropicalis MC5R using cDNA
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine.
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 645 base
pairs. Lane 1-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane
2-interrenal/kidney cDNA (positive control), Lane 3-Negative control of heart (no RT),
Lane 4-heart cDNA, Lane 5-Negative control of brain (no RT), Lane 6-brain cDNA,
Lane 7-Negative control of liver (no RT), Lane 8-liver cDNA, Lane 9-Negative control
of muscle (no RT), Lane 10-muscle cDNA, Lane 11-Negative control of ovaries (no RT),
Lane 12-ovaries cDNA, Lane 13-Negative control of intestine (no RT), Lane 14-intestine
cDNA.
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Figure 12: PCR analysis of tissue distribution of X. tropicalis MRAP using cDNA
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine.
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 185 base
pairs. Lane 1-interrenal/kidney cDNA (positive control, arrow points to expected band),
Lane 2-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane 3Negative control of heart (no RT), Lane 4-heart cDNA, Lane 5-Negative control of brain
(no RT), Lane 6-brain cDNA, Lane 7-Negative control of liver (no RT), Lane 8-liver
cDNA, Lane 9-Negative control of muscle (no RT), Lane 10-muscle cDNA, Lane 11Negative control of ovaries (no RT), Lane 12-ovaries cDNA, Lane 13-Negative control
of intestine (no RT), Lane 14-intestine cDNA.
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base pairs and was detected as expected from the interrenal/kidney tissue (Figure 13:
Lane 2), in addition to the brain and muscle (Figure 13: Lane 6 and 9 respectively). No
visible bands were detected in any of the negative controls (Figure 13: Lanes 1, 3, 5, 7,
10, 11, 13).
Since MC2R, MC5R, MRAP, and MRAP2 were found in the interrenal/kidney
tissue of X. tropicalis, the next logical step was to analyze the pharmacological
interaction of all of these proteins by expressing them in CHO cells. CHO cells are a
good model system to study melanocortin receptors, because they do not endogenously
express melanocortin receptors or the accessory proteins: MRAP and MRAP2 (Chung et
al., 2008).
Functional interaction of MC2R, MC5R, MRAP, and MRAP2
CHO cells were transfected with different combinations of the receptors MC2R,
MC5R, and the accessory proteins MRAP and MRAP2. To measure the amount of cAMP
that was produced by MC2R and MC5R upon stimulation with either ACTH or -MSH
all transfections were done using a CRE-luciferase reporter gene. After being stimulated
by the respective ligand, the amount of cAMP generated by the receptors was measured
indirectly based on the amount of luminescence produced after the luciferase substrate
was added.

Ligand selectivity of MC2R and MC5R
To characterize the ligand selectivity of frog MC2R, CHO cells were transiently
transfected with xtMC2R in the presence and absence of (mouse) mMRAP, and
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Figure 13: PCR analysis of tissue distribution of X. tropicalis MRAP2 using cDNA
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine.
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 312 base
pairs. Lane 1-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane
2-interrenal/kidney cDNA (positive control), Lane 3-Negative control of heart (no RT),
Lane 4-heart cDNA, Lane 5-Negative control of brain (no RT), Lane 6-brain cDNA,
Lane 7-Negative control of liver (no RT), Lane 8-liver cDNA, Lane 9-muscle cDNA,
Lane 10-Negative control of muscle (no RT), Lane 11-Negative control of ovaries (no
RT), Lane 12-ovaries cDNA, Lane 13-Negative control of intestine (no RT), Lane 14intestine cDNA.
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stimulated with ACTH or -MSH. Activation of frog MC2R was only observed when the
receptor was cotransfected with MRAP and stimulated by ACTH, but not in the absence
of MRAP or if stimulated by -MSH (Figure 14). Next, the ligand selectivity of frog
MC5R was analyzed by transfecting CHO cells with xtMC5R and stimulating them with
ACTH and -MSH (Figure 15). Although it seemed that xtMC5R has a slight preference
for ACTH (EC50 = 1.6 x 10-9 M) over -MSH (EC50 = 8.3 x 10-9 M), the difference was
only about 5-fold (p<0.05).

Effect of MRAP on MC2R and MC5R
As previously shown, MRAP is required by xtMC2R for activation by ACTH and
in this assay was used as a control to compare the sensitivity of MC2R vs. MC5R (Figure
16). xtMC2R coexpressed with mMRAP (EC50 = 1.1 x 10-10 M) was about 10-fold more
sensitive than xtMC5R (EC50 = 1.2 x 10-9 M) when stimulated with ACTH (Table 3,
p<0.05). To test the hypothesis that MRAP will have a negative effect on MC5R
trafficking to the plasma membrane and therefore activation of the receptor, xtMC5R was
coexpressed with mMRAP and stimulated with ACTH (Figure 16). The coexpression of
the frog MC5R with mMRAP made the receptor more sensitive to ACTH (EC50 = 8.7 x
10-11 M) and resulted in a 13-fold shift in the EC50 value of the receptor (Table 3,
p<0.05). There was no significant difference in EC50 values for xtMC2R and xtMC5R
when both receptors were coexpressed with mMRAP and stimulated with ACTH.
Similarly, to assess whether activation of xtMC5R with -MSH was affected by the
presence of mMRAP, xtMC5R was coexpressed with mMRAP and stimulated with 36

Figure 14: Ligand selectivity of xtMC2R. Transient transfections of CHO cells with
xtMC2R with and without mMRAP and stimulated with frog ACTH 1-24 and frog MSH from 10-12 to 10-6 M. The CRE-luciferase units correspond to the amount of cAMP
produced upon stimulation at each concentration. Each transfection was done in
triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 value of
xtMC2R/mMRAP stimulated with ACTH (squares) is 1.6 x 10-10 M +/- 3.1 x 10-11. Also
shown are xtMC2R without MRAP stimulated with ACTH (circles), and xtMC2R with
mMRAP stimulated with -MSH (diamonds).
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Figure 15: Ligand selectivity of xtMC5R. Transient transfections of CHO cells with
xtMC5R and stimulated with frog ACTH 1-24 and frog -MSH from 10-12 to 10-6 M. The
CRE-luciferase units correspond to the amount of cAMP produced upon stimulation at
each concentration. Each transfection was done in triplicates and the mean +/- S.E.M. is
plotted for each data point. The EC50 values are the following: xtMC5R stimulated with
ACTH (circles) 1.6 x 10-9 M +/- 5.9 x 10-10, and xtMC5R stimulated with -MSH
(squares) 8.3 x 10-9 M +/- 2.9 x 10-9, p=0.04.
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Figure 16: Effect of mMRAP on xtMC2R and xtMC5R when stimulated with ACTH.
Transient transfections of CHO cells with xtMC2R, xtMC5R, mMRAP and stimulated
with frog ACTH 1-24 from 10-12 to 10-6 M. The CRE-luciferase units correspond to the
amount of cAMP produced upon stimulation at each concentration. Each transfection was
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values
are the following: xtMC2R/mMRAP (circles) 1.1 x 10-10 M +/- 3.4 x 10-11, xtMC5R
(squares) 1.2 x 10-9 M +/- 3.3 x 10-10, and xtMC5R/mMRAP (diamonds) 8.7 x 10-11 M
+/- 2.5 x 10-11. Statistical analysis shown in Table 3.
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Table 3: Statistical analysis for Figure 16. Student’s t-test for the mean EC50 values +/S.E.M for the transfections shown in Figure 16. P-values listed and (*) indicates p<0.05.
P-value
xtMC2R/mMRAP
xtMC5R
0.02*
-10
-11
-9
-10
1.1 x 10

M +/- 3.4 x 10

1.2 x 10 M +/- 3.3 x 10

xtMC2R/mMRAP

xtMC5R/mMRAP

1.1 x 10-10 M +/- 3.4 x 10-11

8.7 x 10-11 M +/- 2.5 x 10-11

xtMC5R

xtMC5R/mMRAP

1.2 x 10-9 M +/- 3.3 x 10-10

8.7 x 10-11 M +/- 2.5 x 10-11
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0.30
0.02*

MSH (Figure 17). There was no significant difference in the EC50 values when xtMC5R
(EC50 = 1.0 x 10-8 M) was expressed alone, or when coexpressed with mMRAP (EC50 =
4.9 x 10-9 M). Figure 18 summarizes the previous observations on the effect of mMRAP
on the ligand selectivity of xtMC5R.

Effect of MRAP2 on MC2R and MC5R
The next step was to analyze the effect of xtMRAP2 on both xtMC2R and
xtMC5R. Coexpression of xtMRAP2 with xtMC2R led to a 919–fold shift in the EC50
value making the receptor significantly less sensitive to ACTH (Figure 19: EC50 = 1.0 x
10-7 M) when compared to xtMC2R coexpressed with mMRAP (Figure 16: EC50 = 1.1 x
10-10 M; p<0.05). In contrast, xtMRAP2 increased the sensitivity of xtMC5R to ACTH
by about 10-fold. The EC50 value for xtMC5R shifted from 1.2 x 10-9 M when expressed
alone to 1.3 x 10-10 M when coexpressed with xtMRAP2 (Figure 19; p<0.01). The frog
MC5R expressed alone or coexpressed with xtMRAP2 was significantly more sensitive
to ACTH, when either transfection is compared to the sensitivity of xtMC2R coexpressed
with xtMRAP2 (Table 4, p<0.05). xtMC5R coexpressed with xtMRAP2 was about 803fold more sensitive to ACTH compared to xtMC2R with xtMRAP2. To test whether
xtMRAP2 affected the affinity of xtMC5R to -MSH, the receptor was also coexpressed
with xtMRAP2 and stimulated with -MSH (Figure 20). No significant difference was
observed in the sensitivity of xtMC5R to -MSH when expressed alone (EC50 = 1.0 x 108

M) or coexpressed with xtMRAP2 (EC50 = 2.2 x 10-8 M). The ligand selectivity of frog

MC5R in the presence and absence of xtMRAP2 are summarized in Figure 21.
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Figure 17: Effect of mMRAP on xtMC5R when stimulated with -MSH. Transient
transfections of CHO cells with xtMC5R, mMRAP and stimulated with frog -MSH
from 10-12 to 10-6 M. The CRE-luciferase units correspond to the amount of cAMP
produced upon stimulation at each concentration. Each transfection was done in
triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values are the
following: xtMC5R (circles) 1.0 x 10-8 M +/- 5.4 x 10-9, and xtMC5R/mMRAP (squares)
4.9 x 10-9 M +/- 1.9 x 10-9, p=0.21.
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Figure 18: Ligand selectivity of xtMC5R when coexpressed with and without mMRAP.
Transient transfections of CHO cells with xtMC5R with and without mMRAP and
stimulated with frog ACTH 1-24 and frog -MSH from 10-12 to 10-6 M. The CREluciferase units correspond to the amount of cAMP produced upon stimulation at each
concentration. Each transfection was done in triplicates and the mean +/- S.E.M. is
plotted for each data point. The EC50 values are the following: xtMC5R stimulated with
ACTH (circles) is 1.2 x 10-9 M +/- 3.3 x 10-10, xtMC5R/mMRAP stimulated with ACTH
(squares) 8.7 x 10-11 M +/- 2.5 x 10-11, xtMC5R stimulated with -MSH (diamonds) is
1.0 x 10-8 M +/- 5.4 x 10-9, xtMC5R/mMRAP stimulated with -MSH (half-filled
squares) 4.9 x 10-9 M +/- 1.9 x 10-9.
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Figure 19: Effect of xtMRAP2 on xtMC2R and xtMC5R when stimulated with ACTH.
Transient transfections of CHO cells with xtMC2R, xtMC5R, xtMRAP2 and stimulated
with frog ACTH 1-24 from 10-12 to 10-6 M. The CRE-luciferase units correspond to the
amount of cAMP produced upon stimulation at each concentration. Each transfection was
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values
are the following: xtMC2R/xtMRAP2 (circles) 1.0 x 10-7 M +/- 3.2 x 10-8, xtMC5R
(squares) 1.2 x 10-9 M +/- 2.2 x 10-10, and xtMC5R/xtMRAP2 (diamonds) 1.3 x 10-10 M
+/- 5.0 x 10-11. Statistical analysis shown in Table 4.
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Table 4: Statistical analysis for Figure 19. Student’s t-test for the mean EC50 values +/S.E.M for the transfections shown in Figure 19. P-values listed and (*) indicates p<0.05,
(**) indicates p<0.01.
P-value
xtMC2R/xtMRAP2
xtMC5R
0.02*
-7
-8
-9
-10
1.0 x 10 M +/- 3.2 x 10

xtMC2R/xtMRAP2
-7

1.2 x 10 M +/- 2.2 x 10

xtMC5R/xtMRAP2
-8

1.3 x 10-10 M +/- 5.0 x 10-11

xtMC5R

xtMC5R/xtMRAP2

1.2 x 10-9 M +/- 2.2 x 10-10

1.3 x 10-10 M +/- 5.0 x 10-11

1.0 x 10 M +/- 3.2 x 10
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0.02*
0.004**

Figure 20: Effect of xtMRAP2 on xtMC5R when stimulated with -MSH. Transient
transfections of CHO cells with xtMC5R, xtMRAP2 and stimulated with frog -MSH
from 10-12 to 10-6 M. The CRE-luciferase units correspond to the amount of cAMP
produced upon stimulation at each concentration. Each transfection was done in
triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values are the
following: xtMC5R (circles) 1.0 x 10-8 M +/- 5.4 x 10-9, and xtMC5R/xtMRAP2
(squares) 2.2 x 10-8 M +/- 8.3 x 10-9, p=0.15.
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Figure 21: Ligand selectivity of xtMC5R when coexpressed with and without xtMRAP2.
Transient transfections of CHO cells with xtMC5R with and without xtMRAP2 and
stimulated with frog ACTH 1-24 and frog -MSH from 10-12 to 10-6 M. The CREluciferase units correspond to the amount of cAMP produced upon stimulation at each
concentration. Each transfection was done in triplicates and the mean +/- S.E.M. is
plotted for each data point. The EC50 values are the following: xtMC5R stimulated with
ACTH (circles) is 1.2 x 10-9 M +/- 3.3 x 10-10, xtMC5R/xtMRAP2 stimulated with ACTH
(squares) 1.3 x 10-10 M +/- 7.7 x 10-11, xtMC5R stimulated with -MSH (diamonds) is
1.0 x 10-8 M +/- 5.4 x 10-9, xtMC5R/xtMRAP2 stimulated with -MSH (half-filled
squares) 2.2 x 10-8 M +/- 8.3 x 10-9.
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Since the cloning experiments revealed a small region of MRAP that was highly
similar to the chicken MRAP, it made sense to test the effect of chicken MRAP on the
ligand selectivity of MC5R. Consistent with experiments using the mouse MRAP, the
chicken MRAP also increased the sensitivity of xtMC5R to ACTH and caused a 383-fold
shift in the EC50 value from 1.5 x 10-9 M to 3.8 x 10-12 M (Figure 22; p<0.05). The effect
that the chicken MRAP had on xtMC5R was comparable to the effect that xtMRAP2 had
on xtMC5R when stimulated with ACTH. On the other hand, neither chicken MRAP or
xtMRAP2 changed the sensitivity of xtMC5R to -MSH (Figure 23).

Effect of both MRAPs on MC2R and MC5R
Due to previous findings that have shown that MRAP and MRAP2 have the
ability to form a heterodimer (Chan et al., 2009), both xtMC2R and xtMC5R were
coexpressed with mMRAP and xtMRAP2. There was no change in the sensitivity of
xtMC2R to ACTH when the receptor was coexpressed with both mMRAP and xtMRAP2
(Figure 24). However, there was about three times more cAMP produced when xtMC2R
was coexpressed with both MRAPs (p<0.001). Both MRAPs coexpressed with xtMC5R
increased the sensitivity of the receptor to ACTH (Figure 25; p<0.05). Coexpression of
both MRAPs with xtMC5R caused a shift in the EC50 value from 1.2 x 10-9 M to 8.0 x 1011

M, and resulted in a slight but significant increase in cAMP (p<0.001). There was no

significant difference in the sensitivity of the receptor when xtMC5R was coexpressed
with both MRAPs and stimulated with -MSH (Figure 26), but there was over twice as
much cAMP produced (p<0.001).
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Figure 22: Effect of chicken MRAP and xtMRAP2 on xtMC5R when stimulated with
ACTH. Transient transfections of CHO cells with xtMC5R, chicken MRAP, xtMRAP2
and stimulated with frog ACTH 1-24 from 10-12 to 10-6 M. The CRE-luciferase units
correspond to the amount of cAMP produced upon stimulation at each concentration.
Each transfection was done in triplicates and the mean +/- S.E.M. is plotted for each data
point. The EC50 values are the following: xtMC5R (circles) 1.5 x 10-9 M +/- 5.5 x 10-10,
xtMC5R/chicken MRAP (squares) 3.8 x 10-12 M +/- 3.4 x 10-12, and xtMC5R/xtMRAP2
(diamonds) 3.4 x 10-11 M +/- 1.5 x 10-11. Statistical analysis shown in Table 5.
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Table 5: Statistical analysis for Figure 22. Student’s t-test for the mean EC50 values +/S.E.M for the transfections shown in Figure 22. P-values listed and (*) indicates p<0.05.
P-value
xtMC5R
xtMC5R/chicken MRAP
0.03*
-9
-10
-12
-12
1.5 x 10 M +/- 5.5 x 10

3.8 x 10

M +/- 3.4 x 10

xtMC5R

xtMC5R/xtMRAP2

1.5 x 10-9 M +/- 5.5 x 10-10

3.4 x 10-11 M +/- 1.5 x 10-11

xtMC5R/chicken MRAP

xtMC5R/xtMRAP2

3.8 x 10-12 M +/- 3.4 x 10-12

3.4 x 10-11 M +/- 1.5 x 10-11
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0.03*
0.06

Figure 23: Effect of chicken MRAP and xtMRAP2 on xtMC5R and stimulated with MSH. Transient transfections of CHO cells with xtMC5R, chicken MRAP, xtMRAP2
and stimulated with frog -MSH from 10-12 to 10-6 M. The CRE-luciferase units
correspond to the amount of cAMP produced upon stimulation at each concentration.
Each transfection was done in triplicates and the mean +/- S.E.M. is plotted for each data
point. The EC50 values are the following: xtMC5R (circles) 1.1 x 10-8 M +/- 7.0 x 10-9,
xtMC5R/chicken MRAP (squares) 2.2 x 10-9 M +/- 1.3 x 10-9, and xtMC5R/xtMRAP2
(diamonds) 1.6 x 10-8 M +/- 4.9 x 10-9. Statistical analysis shown in Table 6.
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Table 6: Statistical analysis for Figure 23. Student’s t-test for the mean EC50 values +/S.E.M for the transfections shown in Figure 23. P-values listed and (*) indicates p<0.05.
P-value
xtMC5R
xtMC5R/chicken MRAP
0.15
-8
-9
-9
-9
1.1 x 10 M +/- 7.0 x 10

2.2 x 10 M +/- 1.3 x 10

xtMC5R

xtMC5R/xtMRAP2

1.1 x 10-8 M +/- 7.0 x 10-9

1.6 x 10-8 M +/- 4.9 x 10-9

xtMC5R/chicken MRAP

xtMC5R/xtMRAP2

2.2 x 10-9 M +/- 1.3 x 10-9

1.6 x 10-8 M +/- 4.9 x 10-9
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0.30
0.03*

Figure 24: Effect of mMRAP and xtMRAP2 on xtMC2R when stimulated with ACTH.
Transient transfections of CHO cells with xtMC2R, mMRAP, xtMRAP2 and stimulated
with frog ACTH 1-24 from 10-12 to 10-6 M. The CRE-luciferase units correspond to the
amount of cAMP produced upon stimulation at each concentration. Each transfection was
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values
are the following: xtMC2R/mMRAP (circles) 1.1 x 10-10 M +/- 3.4 x 10-11, and
xtMC2R/mMRAP/xtMRAP2 (squares) 2.0 x 10-10 M +/- 1.1 x 10-10, p=0.24.
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Figure 25: Effect of mMRAP and xtMRAP2 on xtMC5R when stimulated with ACTH.
Transient transfections of CHO cells with xtMC5R, mMRAP, xtMRAP2 and stimulated
with frog ACTH 1-24 from 10-12 to 10-6 M. The CRE-luciferase units correspond to the
amount of cAMP produced upon stimulation at each concentration. Each transfection was
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values
are the following: xtMC5R (circles) 1.2 x 10-9 M +/- 3.3 x10-10, and
xtMC5R/mMRAP/xtMRAP2 (squares) 8.0 x 10-11 M +/- 3.1 x 10-11, p=0.02.
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Figure 26: Effect of mMRAP and xtMRAP2 on xtMC5R and stimulated with -MSH.
Transient transfections of CHO cells with xtMC5R, mMRAP, xtMRAP2 and stimulated
with frog -MSH from 10-12 to 10-6 M. The CRE-luciferase units correspond to the
amount of cAMP produced upon stimulation at each concentration. Each transfection was
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values
are the following: xtMC5R (circles) 2.3 x 10-8 M +/- 1.0 x 10-8, and
xtMC5R/mMRAP/xtMRAP2 (squares) 1.2 x 10-8 M +/- 4.1 x 10-9, p=0.20.
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Interaction of MC2R, MC5R, MRAP, and MRAP2
After analyzing the effect of MRAP and MRAP2 on each individual receptor, the
interaction of all these proteins was examined. CHO cells were transfected with xtMC2R,
xtMC5R, mMRAP, and xtMRAP2 and stimulated with ACTH (Figure 27). The EC50
value was 1.4 x 10-10 M and was comparable to the control xtMC2R and mMRAP (1.1 x
10-10 M); however, the level of cAMP was four times as much when all proteins were
expressed (p<0.001). The contribution of xtMC2R/mMRAP was studied by using a
mutant xtMC2R receptor in which the isoleucine at position 175 had been substituted by
an alanine (xtMC2R I-175) (Figure 28). When compared to wild type MC2R, the mutant
MC2R I-175 was not nearly as efficient as the wild type MC2R when stimulated by
ACTH (p<0.01). There was a 526-fold shift in response to ACTH from an EC50 of 3.1 x
10-10 M from the wild type receptor to an EC50 of 1.6 x 10-7 M from the mutant receptor.
Even if the mutant receptor xtMC2R I-175 was coexpressed with both MRAPs, the
mutant receptor was not nearly as efficient as the wild type receptor (p<0.01).
Coexpression of mutant MC2R I-175 with xtMRAP2 completely abolished activation by
ACTH. Mutant xtMC2R I-175 coexpressed with xtMC5R, mMRAP, and xtMRAP2
resulted in a similar EC50 value compared to wild type xtMC2R, but did not result in a
significant increase cAMP (p>0.05).
Likewise, expression of xtMC2R, xtMC5R, mMRAP, and xtMRAP2 were
compared to xtMC5R (Figure 29). The receptor on its own was sixteen times less
sensitive to ACTH and had an EC50 of 1.2 x 10-9 M versus an EC50 of 7.2 x 10-11 M when
coexpressed with MC2R and both MRAPs (p<0.05). When both receptors and both
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Figure 27: Transient transfection of CHO cells with xtMC2R, xtMC5R, mMRAP,
xtMRAP2 compared to xtMC2R/mMRAP when stimulated with frog ACTH 1-24 from
10-12 to 10-6 M. The CRE-luciferase units correspond to the amount of cAMP produced
upon stimulation at each concentration. Each transfection was done in triplicates and the
mean +/- S.E.M. is plotted for each data point. The EC50 values are the following:
xtMC2R/mMRAP (circles) 1.1 x 10-10 M +/- 3.4 x 10-11, and
xtMC2R/mMRAP/xtMRAP2/xtMC5R (squares) 1.4 x 10-10 M +/- 4.9 x 10-11, p=0.34.
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Figure 28: Contribution of wild type xtMC2R/mMRAP when stimulated with ACTH.
Transient transfection of CHO cells with mutant xtMC2R I-175, xtMC5R, mMRAP, and
xtMRAP2 compared to wild type xtMC2R when stimulated with frog ACTH 1-24 from
10-12 to 10-6 M. The CRE-luciferase units correspond to the amount of cAMP produced
upon stimulation at each concentration. Each transfection was done in triplicates and the
mean +/- S.E.M. is plotted for each data point. The EC50 values are the following:
xtMC2R/mMRAP (filled circles) 3.1 x 10-10 M +/- 2.8 x 10-11, xtMC2R I-175/mMRAP
(squares) 1.6 x 10-7 M +/- 3.3 x 10-8, xtMC2R I-175/mMRAP/xtMRAP2 (half-filled
squares) 1.2 x 10-7 M +/- 2.9 x 10-8, xtMC2R I-175/mMRAP/xtMRAP2/xtMC5R (open
circles) 2.0 x 10-9 M +/- 1. 9 x 10-9. Also shown xtMC2R I-175/xtMRAP2 (triangles).
Statistical analysis shown in Table 7.
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Table 7: Statistical analysis for Figure 28. Student’s t-test for the mean EC50 values +/S.E.M for the transfections shown in Figure 28. P-values listed and (*) indicates p<0.05,
(**) indicates p<0.01.
P-value
xtMC2R/mMRAP
xtMC2R I-175/mMRAP
0.004**
-10
-11
-7
-8
3.1 x 10

M +/- 2.8 x 10

xtMC2R/mMRAP
3.1 x 10-10 M +/- 2.8 x 10-11

xtMC2R/mMRAP
-10

3.1 x 10

-11

M +/- 2.8 x 10

xtMC2R I-175/
mMRAP/xtMRAP2/xtMC5R
-9

-9

2.0 x 10 M +/- 1.9 x 10

xtMC2R I-175/
mMRAP/xtMRAP2/xtMC5R
-9

-9

2.0 x 10 M +/- 1.9 x 10

1.6 x 10 M +/- 3.3 x 10

xtMC2R I-175/
mMRAP/xtMRAP2

0.007**

1.2 x 10-7 M +/- 2.9 x 10-8

xtMC2R I-175/
mMRAP/xtMRAP2/xtMC5R

0.21

2.0 x 10-9 M +/- 1.9 x 10-9

xtMC2R I-175/mMRAP
1.6 x 10-7 M +/- 3.3 x 10-8

xtMC2R I-175/
mMRAP/xtMRAP2
-7

1.2 x 10 M +/- 2.9 x 10
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0.004**
0.007**

-8

Figure 29: Transient transfection of CHO cells with xtMC2R, xtMC5R, mMRAP,
xtMRAP2 compared to xtMC5R when stimulated with frog ACTH 1-24 from 10-12 to 106
M. The CRE-luciferase units correspond to the amount of cAMP produced upon
stimulation at each concentration. Each transfection was done in triplicates and the mean
+/- S.E.M. is plotted for each data point. The EC50 values are the following: xtMC2R
(circles) 1.2 x 10-9 M +/- 3. 3 x 10-10, and xtMC2R/mMRAP/xtMRAP2/xtMC5R
(squares) 7.2 x 10-11 M +/- 4.0 x 10-11, p=0.01.
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accessory proteins were expressed together they produced almost five times more cAMP
than xtMC5R by itself (p<0.001). To study this interaction further, a mutant xtMC5R
with alanine substitutions at amino acid positions 92, 114, and 119 (xtMC5R
A/92/114/119) was coexpressed with xtMC2R, mMRAP, and xtMRAP2 and compared to
wild type xtMC5R (Figure 30). Mutant xtMC5R A92/114/119 alone or coexpressed with
any of the MRAPs failed to be activated by ACTH. The coexpression of mutant xtMC5R
A/92/114/119 with xtMC2R, mMRAP, and xtMRAP2 did not result in a significant shift
in the EC50 value when compared the wild type xtMC5R. However there was about five
and a half times more cAMP produced when mutant xtMC5R A92/114/119 was
coexpressed with xtMC2R, mMRAP, and xtMRAP2.
In contrast, expression of xtMC5R alone compared to expression of xtMC5R,
xtMC2R, mMRAP, and xtMRAP2 did not change sensitivity to -MSH (Figure 31). The
EC50 value remained in the 10-8 M range.
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Figure 30: Contribution of wild type xtMC5R when stimulated with ACTH. Transient
transfection of CHO cells with mutant xtMC5R A92/114/119, xtMC2R, mMRAP, and
xtMRAP2 compared to wild type xtMC5R when stimulated with frog ACTH 1-24 from
10-12 to 10-6 M. The CRE-luciferase units correspond to the amount of cAMP produced
upon stimulation at each concentration. Each transfection was done in triplicates and the
mean +/- S.E.M. is plotted for each data point. The EC50 values are the following:
xtMC5R (circles) 9.8 x 10-10 M +/- 5.4 x 10-10, and xtMC5R
A92/114/119/xtMC2R/mMRAP/xtMRAP2 (half-filled squares) 8.9 x 10-10 M +/- 2.8 x
10-10. Also shown are xtMC5R A92/114/119 (squares) and xtMC5R
A92/114/119/xtMC2R/mMRAP/xtMRAP2 (triangles), P-value between xtMC5R and
xtMC5R A92/114/119/xtMC2R/mMRAP/xtMRAP2, p=0.45.

62

Figure 31: Transient transfection of CHO cells with xtMC2R, xtMC5R, mMRAP, and
xtMRAP2 compared to xtMC5R when stimulated with frog -MSH from 10-12 to 10-6 M.
The CRE-luciferase units correspond to the amount of cAMP produced upon stimulation
at each concentration. Each transfection was done in triplicates and the mean +/- S.E.M.
is plotted for each data point. The EC50 values are the following: xtMC5R (circles) 1.0 x
10-8 M +/- 5.4 x 10-9, and xtMC5R/mMRAP/xtMRAP2/xtMC2R (squares) 7.7 x 10-8 M
+/- 3.4 x 10-8, p=0.06.
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Discussion
The primary aim of this study was to understand the role of melanocortin
receptors (MC2R and MC5R) and the accessory proteins (MRAP and MRAP2) in the
HPI-axis of the amphibian Xenopus tropicalis, and to test whether the function of this
system is similar to the mammalian HPA-axis. It was hypothesized that X. tropicalis
MC2R, MC5R, MRAP, and MRAP2 would be expressed in the interrenal gland.
Additionally, it was predicted that the interaction of these proteins would be comparable
to what Sebag and Hinkle (2009a) previously published for the mammalian MC2R,
MC5R, MRAP, and MRAP2 in the adrenal gland. Based on their observations MRAP
should facilitate trafficking of X. tropicalis MC2R to the plasma membrane and enable
activation by ACTH, but MRAP and MRAP2 should inhibit cell surface expression of
MC5R and no activation should be achieved by either ACTH or -MSH. In this study
RT-PCR performed on the interrenal/kidney tissue of the frog confirmed the expression
of MC2R, MC5R, MRAP, and MRAP2. Furthermore, through testing the interaction of
these four proteins in vitro it was verified that MRAP was required for MC2R activation
by ACTH, but unlike the mammalian system MRAP and MRAP2 did not inhibit MC5R
activation by ACTH or -MSH.
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Cloning and expression patterns of MC2R, MC5R, MRAP, MRAP2
The results obtained from PCR and sequencing verified the presence of MC2R,
MC5R, MRAP, and MRAP2 in the frog interrenal/kidney tissue (See Figures 5-9). This
fits in line with earlier studies that have shown coexpression of MC2R and MC5R in
other organisms including the adrenals in mammals (Sebag and Hinkle, 2009a), and the
head kidney of fish (Kobayashi et al., 2011). The significance of the coexpression of
MC2R and MC5R in the same cell type could be the result of the proposed common
origin of these two receptors (See Figure 32). It has been hypothesized that MC2R and
MC5R are the result of a local gene duplication that occurred in an MC2R/MC5R gene
(Dores, 2013). This could provide a possible explanation as to why both receptors were
found in the interrenal tissue of the frog. The two accessory proteins MRAP and MRAP2
were also found in the interrenal/kidney tissue. Since MRAP has not yet been identified
in the X. tropicalis genome, degenerate primers designed from conserved regions of
MRAP were used in the PCR reaction. From the sequencing results, a 185 base pair
region of MRAP was obtained that matched the chicken MRAP sequence (Figure 9). This
region contains the domain that is responsible for facilitating MC2R trafficking to the
plasma membrane and the transmembrane spanning domain (Liang et al., 2011). The
sequenced portion of X. tropicalis MRAP was highly similar to the chicken MRAP both
at the nucleotide and amino acid level. For MRAP the N-terminal region and
transmembrane spanning domain are highly conserved and the region cloned from the
frog interrenal was almost identical to the chicken MRAP. Currently the sequencing of
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Figure 32: Proposed outline for the evolution of melanocortin receptors (MCRs). This
diagram shows the prediction of how two genome duplication events and one local gene
duplication could have given rise to the five known MCRs. This schematic predicts that
MC4R was the ancestral MCR. Receptors in a dashed box have not yet been identified
and the dashed lines indicate the hypothesis that melanocortin receptors 2 and 5 are the
result of a local gene duplication from an MC2R/MC5R gene. (Figure adapted from
Dores, 2013).
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MRAP from the interrenal tissue is being repeated to ensure that the results obtained here
were not due to contamination.
One caveat to the results obtained from the RT-PCR experiments is that due to the
difficulty of extracting the interrenal tissue, a small portion of the kidney had to be
extracted along with it; therefore, the possibility that some of these genes were cloned
from the small portion of the kidney cannot be ruled out. Another factor that must be
considered is that although both receptors and accessory proteins were cloned from the
interrenal tissue, these results do not provide definitive proof that all four genes are being
expressed in the glucocorticoid producing cells.
After determining that the primers for MC2R, MC5R, MRAP, and MRAP2 had
amplified the target sequence, the primers were tested on other frog tissues to look at the
expression pattern of these genes (Figures 10-13). The tissues analyzed were
interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine. Expression of MC2R
was positive for the interrenal/kidney, heart, ovaries, and a very faint band was observed
in muscle (Figure 10). Expression in the interrenal tissue and ovaries of the frog is
consistent with tissue expression studies of MC2R in mice (Nimura et al., 2006) and in
fish (Aluru and Vijayan, 2008) that have shown that MC2R is also found in the
adrenal/interrenal tissue and the ovaries/testis of these organisms. The next gene to be
analyzed in the frog was MC5R and expression was detected in the interrenal/kidney,
brain, muscle, ovaries, and intestine (Figure 11). These findings are in agreement with
several studies in mammals that have shown that MC5R has the widest range of tissue
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distribution (Gantz et al, 1994; Fathi et al., 1995; Chen et al., 1997; Nimura et al., 2006).
These studies have found varying levels of expression of MC5R in the mouse adrenal
gland, exocrine glands, RT2-2 retinal neuronal cells, muscle, skin, spinal cord, brain
stem, kidney, testis, heart, liver, lung, spleen, and adipose tissue. To this date, the only
known function that has been determined for MC5R in mammals is its role in exocrine
gland secretion (Chen et al., 1997), but its role in the other tissues and other species is
still unknown. One important observation from this earlier study was that the HPA-axis
of MC5R knock-out mice was intact, suggesting that in mammals MC5R is not involved
in glucocorticoid secretion despite being found in the adrenal gland. For MRAP, other
than the interrenal/kidney tissue, the degenerate primers failed to detect expression in the
other frog tissues that were analyzed (Figure 12). Failure to detect MRAP in the other
frog tissues could be due to lack of expression, lower expression, or nonspecific binding
of the degenerate primers. To increase the specificity of this screening method, the fulllength sequence of the frog MRAP must be obtained so that gene specific primers can be
designed and these tissues can be screened again. Lastly MRAP2 primers were tested in
the various frog tissues and it was found in interrenal/kidney, brain, and muscle (Figure
13). The team of researchers that discovered MRAP2 showed that it was expressed in the
human brain and adrenal gland (Chan et al., 2009). This group of researchers also showed
that both MRAP and MRAP2 could interact with all five members of the melanocortin
receptor family to regulate their function. A relevant example of this is a recent study
done in which it was shown that MRAP2 proteins alter the function of MC4R in the brain
to regulate energy homeostasis during the development of zebrafish (Sebag et al., 2013).
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Therefore, finding MRAP2 in the frog brain was not surprising and it is likely that
MRAP2 could also involved in regulating the function of the frog MC4R in the brain.

Modeling the interaction of frog MC2R, MC5R, MRAP, MRAP2 in CHO cells
Another objective of the present study was to recreate the internal environment of
the frog interrenal cell. This was implemented through transient transfections of CHO
cells with varying combinations of xtMC2R, xtMC5R, mMRAP, and xtMRAP2 and
stimulating the cells with ACTH or -MSH. This was done to enable the characterization
of the functional interaction of the proteins involved in glucocorticoid secretion during
activation of the HPI-axis. Collectively, the observations from the transfection
experiments give indication that the interaction of MC2R, MC5R, MRAP, and MRAP2
in Xenopus tropicalis differs from the mammalian system, specifically with respect to the
function of MC5R.
First, it was shown that similar to mammals, functional activation of the frog
MC2R by ACTH requires coexpression with MRAP, and that despite coexpression of
xtMC2R with MRAP no activation was observed when the cells were stimulated with MSH (Figure 14). The ligand selectivity of MC2R for ACTH and requirement for MRAP
has been well established for mammals, birds, reptiles, and amphibians (Barlock et al.,
2014; Agulleiro et al., 2010; Liang et al., 2011; Davis et al., 2013). In addition, the
HFRW and KKRRP motifs on ACTH have been shown to be important for proper
activation of MC2R (Costa et al., 2004; Davis et al., 2013). This means that MC2R must
have a binding site not only for the HFRW domain of ACTH, but also for KKRRP, which
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is not present in any of the MSH-ligands. Another similarity to the mammalian MC2R is
that MRAP2 did not completely abolish activation of xtMC2R to ACTH, but greatly
reduced the sensitivity of the receptor (Figure 19). This is consistent with the finding that
MRAP2 can interact with MC2R, but it is not nearly as efficient as MRAP for trafficking
to the plasma membrane or functional activation by ACTH (Chan et al., 2009).
Subsequently it was determined that unlike the mammalian MC5R, the function
of the amphibian MC5R was not inhibited by the presence of MRAPs. When xtMC5R
was coexpressed with MRAP, MRAP2, or a combination of both MRAPs, the receptor
became significantly more sensitive to ACTH (See Figures 16,19, 22, 25). From the
sequencing results, it was not surprising that the chicken MRAP had the greatest effect on
xtMC5R and increased the sensitivity to ACTH by three orders of magnitude from 1.5 x
10-9 M (alone) to 3.8 x 10-12 M (with MRAP) (Figure 22). Interestingly, when either
MC2R or MC5R were coexpressed with both MRAPs and stimulated with ACTH, the
amount of cAMP produced was 2-3 times as much (See Figures 24 and 25). This can be
an indication that the receptor might be interacting with an MRAP-MRAP2 heterodimer,
but further studies must be done to confirm this interaction. Then, even though xtMC5R
had a slight preference for ACTH over -MSH (Figure 15), the effect of MRAPs on
MC5R was also tested when the cells were stimulated with -MSH (See Figures 17, 20,
23, 26). The coexpression of xtMC5R with any of combination of MRAPs did not change
the sensitivity of the receptor to -MSH in either a positive or a negative manner. The
EC50 value of the receptor remained virtually the same regardless of the presence of
MRAPs when xtMC5R was stimulated with -MSH.
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Finally, the interaction of MC2R, MC5R, MRAP, and MRAP2 was analyzed by
transfecting CHO cells with equal amounts of each cDNA construct and stimulating with
ACTH or -MSH. When stimulated with ACTH, the EC50 value obtained when both
receptors and both accessory proteins were present was comparable to xtMC2R/mMRAP
(Figure 27), but when compared to xtMC5R (Figure 29) the EC50 value of all four
proteins was significantly more sensitive. Under both circumstances the amount of cAMP
produced was 4-5 times higher in the presence of both receptors and both accessory
proteins, compared to each receptor on its own. This indicates that both receptors may be
contributing to the overall response when stimulated with ACTH, and that the
combination of both accessory proteins does not have a negative effect on the function of
the receptors. On the other hand, there was no significant difference when the cells were
transfected with xtMC5R alone or when transfected with a combination of xtMC2R,
xtMC5R, mMRAP, and xtMRAP2 and stimulated with -MSH (Figure 31). This is due
to the fact that xtMC2R cannot be activated by -MSH, and that the MRAPs do not have
an effect on MC5R when the receptor is stimulated with -MSH. Therefore, the response
to -MSH comes only from the presence of xtMC5R.
To further understand the interaction of MC2R, MC5R, MRAP, and MRAP2 and
to assess the contribution of each receptor, studies were done using a mutant xtMC2R I175 receptor (Figure 28) and a mutant xtMC5R A92/114/119 receptor (Figure 30). The
mutant xtMC2R I-175 has an alanine substitution at isoleucine position 175. This mutant
MC2R receptor coexpressed with mMRAP (EC50= 1.6 x 10-7 M) has a greatly reduced
sensitivity to ACTH compared to the wild type MC2R with mMRAP (Figure 28; EC50=
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3.1 x 10-10 M; p<0.01). The interaction of xtMC2R I-175 with xtMRAP2 completely
eliminated activation by ACTH, and coexpression with both MRAPs did not change the
sensitivity of the mutant receptor. When the mutant MC2R I-175 is coexpressed with
MC5R and both MRAPs, the response to ACTH was similar to wild type MC2R with
MRAP. This was interesting since mutations can occur in the frog MC2R where ACTH
no longer activates this receptor, but the presence of MC5R and the interaction with
MRAPs almost restores functional activation by ACTH similar to wild type
MC2R/mMRAP. Then, studies were done using a mutant MC5R. The mutant xtMC5R
A92/114/119 has alanine substitutions at amino acid positions 92, 114, 119. These
mutations lie in the transmembrane 2 and transmembrane 3 domains (TM2/TM3) of
MC5R, which are amino acid residues involved in the binding pocket of the receptor
(Yang, 2011). This mutant MC5R did not respond at all to ACTH, alone or in the
presence of MRAPs (Figure 30). However, addition of xtMC2R restores activation by
ACTH and this response was only from activation of xtMC2R, since the mutant xtMC5R
A92/114/119 does not respond to ACTH. When the interaction of xtMC2R, MRAP,
MRAP2, and mutant xtMC5R A92/114/119 is compared to what the wild type xtMC5R
would contribute, it becomes evident that the majority of the cAMP response to ACTH
comes from activation of xtMC2R. Additional studies, such as Co-Immunoprecipitation
(Co-IP), must be performed in order to confirm that this mutant MC5R does interact with
MC2R and the MRAPs, and that this receptor is not being degraded or retained in the ER
due to improper folding.
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Conclusion
Taken together, the results obtained here confirm the hypothesis that all four
proteins MC2R, MC5R, MRAP, and MRAP2 are found in the frog interrenal tissue. Also,
it was confirmed that the interaction of the frog MC2R with MRAP would allow
functional activation of the receptor by ACTH. However, the hypothesis that MRAP and
MRAP2 would have a negative effect on MC5R must be rejected based on the
observations that MRAP and MRAP2 increased the sensitivity of MC5R to ACTH, and
did not change the sensitivity of the receptor to -MSH. When all four proteins were
coexpressed in CHO cells and stimulated with ACTH, the response observed seemed to
be a combined effect of both MC2R and MC5R interacting with MRAP and MRAP2.
From these observations it can be said that at least in vitro, the frog MC5R contributes to
the overall production of cAMP. If this holds true in vivo it means that MC5R also
contributes to glucocorticoid secretion during activation of the HPI-axis.
Nevertheless, the results obtained in this study still leave unresolved the
observation that -MSH does not induce glucocorticoid secretion in vivo (Schwyzer,
1977; Aluru and Vijayan 2008; Kobayashi et al., 2011). Although in mammals the second
highest concentration of the antagonist AGRP has been found in the adrenal gland,
MC2R and MC5R have no affinity for this antagonist (Gantz and Fong, 2003). A possible
mechanism for the selectivity of ACTH over -MSH in the mammalian adrenal cell
could be due to the negative effect that MRAPs have on the cell surface expression of
MC5R. If MC5R cannot reach the cell surface, then it cannot be functionally activated by
-MSH to induce glucocorticoid secretion during the stress response. This does not seem
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to be the case for regulating the ligand selectivity in the frog interrenal cell. It is possible
that in the frog, the levels of -MSH required for activation of MC5R in the interrenal
cell are extremely high, (10-8 M range) which begins to get above physiological levels.
Even if the concentration of -MSH were to reach these levels in vivo, this ligand would
preferentially bind to and activate MCRs that are more sensitive to -MSH, such as
MC1R.

Future directions
The studies presented here only begin to examine the interactions between MC2R,
MC5R, MRAP, and MRAP2, but future studies should be done to further understand the
interaction of these proteins in the frog interrenal cells. First, the sequence of MRAP
should be verified and the full-length MRAP gene should be sequenced. This can be done
through performing 3’ and 5’ RACE (Rapid amplification of cDNA ends) reactions on
the interrenal cDNA to obtain the 3’ and 5’ ends of the frog MRAP gene. Next,
Quantitative RT-PCR (qRT-PCR) can be done to measure the expression levels of
MC2R, MC5R, MRAP, and MRAP2 in the frog interrenal cells. It could be that MC2R
has higher expression levels than MC5R and this could explain why -MSH does not
induce cortisol secretion in vivo. An earlier study showed that ACTH upregulates
expression levels of MC2R in mice and human cell lines (Mountjoy et al., 1994).
Therefore, the frog MC2R and MC5R expression levels could be measured by qRT-PCR
before and after stimulation by ACTH. Additionally, in situ hybridization using RNA
probes could be done on the frog interrenal tissue to determine if MC2R, MC5R, MRAP,
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and MRAP2 are all expressed in the glucocorticoid producing cells. Another experiment
that can be performed is cell surface ELISA to measure the amount of receptor (MC2R or
MC5R) that reaches the cell surface in the presence and absence of MRAPs. Then
another method for analyzing these interactions can be applied such as fluorescent
immunocytochemistry to show the co-localization of the receptors and accessory
proteins. Moreover, it has been shown that other members of the melanocortin receptor
family can form homo- and heterodimers (Mandrika et al., 2005) and Co-IP can be done
to determine whether frog MC2R/MC5R can form heterodimers. In this study, the
pharmacological properties of xtMC2R and xtMC5R when stimulated with ACTH or MSH were also tested, but in either case the response was similar to xtMC5R being
expressed alone (data not shown); however it is possible that MC2R/MC5R do form a
heterodimer. Co-IP can also be used to show that MC2R, MC5R, MRAP, and MRAP2
have the potential to form a complex in vitro, and that this complex might also be formed
in vivo. The work presented here and future work that remains to be done, will help to
provide a further understanding of how the HPA/I-axis has evolved, and the role of
melanocortin receptors and accessory proteins in regulating the function of this system.
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